The Valley Desk

NCT05369403 · Interventional trial

A Study of Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab

Overall registry status Completed

Phase 3

Conditions Atopic Dermatitis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov